Preparation method and application of traditional Chinese medicine external lotion for treating neonatal jaundice

The lotion prepared by the traditional Chinese medicine compositions Scutellaria baicalensis, Cypress, Rhubarb, Tianjihuang, Gardenia, White Soil, Chrysanthemum, Cypress, Cypress, Atractylodes, and Cypress, is aimed at the damp heat-abundant steaming syndrome of neonatal jaundice. The problems of large side effects and insignificant efficacy of existing treatment methods have been solved, and significant efficacy and high safety effects have been achieved.

CN118924846APending Publication Date: 2024-11-12QINGYUAN TRADITIONAL CHINESE MEDICINE HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411045871.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing treatment methods for neonatal jaundice have problems with great side effects and insignificant efficacy, especially the possibility of blue light exposure may cause adverse reactions, and neonatal poor compliance with oral drugs, Chinese medicine external lotions have quick effect but lack systematic composition formulas. .

Method used

Provided is a traditional Chinese medicine composition including scutellaria baicalensis, cypress cypress, rhubarb, celestial yellow, gardenia, white cypress root, chrysanthemum, chrysanthemum, chrysanthemum, celestial yellow grass, celestial yellow grass, celestial yellow grass, celestial yellow grass, celestial yellow grass and cysanthemum, which is prepared into a lotion by extraction and clearing heat and radiating. The effects of gallbladder, removal of dampness and reduction of yellowing are treated for the damp heat-absorbing syndrome of neonatal jaundice.

Benefits of technology

This traditional Chinese medicine composition has significant therapeutic effect, fast effect, and has no toxic side effects. It is suitable for the skin characteristics of neonatal babies. Through the mechanism of clearing heat and removing dampness, promoting gallbladder and reducing yellowing, it effectively reduces bilirubin and improves the effect of treating neonatal jaundice.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924846A_ABST
    Figure CN118924846A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method and application of a traditional Chinese medicine external lotion for treating neonatal jaundice. The traditional Chinese medicine composition for treating neonatal jaundice is prepared from the following raw materials in parts by mass: 30 to 50 parts of radix scutellariae, 10 to 20 parts of cortex phellodendri, 4 to 8 parts of radix et rhizoma rhei, 8 to 12 parts of herba hyperici japonici, 10 to 20 parts of fructus gardeniae, 10 to 20 parts of rhizoma imperatae, 10 to 20 parts of flos chrysanthemi, 8 to 12 parts of herba rabdosiae serra, 30 to 50 parts of herba artemisiae scopariae, 10 to 20 parts of rhizoma atractylodis and 10 to 20 parts of herba desmodii styracifolii. The traditional Chinese medicine composition for treating the neonatal jaundice has the advantages of remarkable curative effect, quick response and no toxic or side effect when being used for treating the neonatal jaundice.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicines, and in particular to a preparation method and application of a traditional Chinese medicine external lotion for treating neonatal jaundice. Background Art

[0002] Neonatal jaundice is one of the common symptoms in the neonatal period, especially in the early neonatal period. The fetus produces too many red blood cells in the mother's body. After birth, as the pulmonary circulation is established, red blood cells are destroyed in large quantities, leading to bilirubin accumulation and causing jaundice. There are two common types of neonatal jaundice: physiological and pathological. The former can disappear on its own over time, while the latter is not only difficult to disappear on its own, but also has the characteristics of rapid progression and repeated attacks. When the serum bilirubin value exceeds 205μmol / L during blood tests, the child is also accompanied by other manifestations. If effective treatment is not taken in time, severe brain damage may occur.

[0003] Blue light irradiation is currently the main method for treating neonatal jaundice in clinical practice. It converts bilirubin into isomers, changes bilirubin from fat-soluble to water-soluble, and is excreted from the body through bile or urine, which has a good effect on the prognosis of the child's condition. In the past, blue light irradiation treatment was mainly continuous irradiation, which lasted for a long time and was more likely to induce adverse reactions. However, neonates have poor compliance with oral medications. On the contrary, the treatment method of traditional Chinese medicine external washing is fast-acting, simple and easy, and has high safety and few side effects. In addition, the skin of neonates is thin and tender, with abundant capillaries, good penetration and absorption, which can achieve the purpose of promoting blood circulation, removing dampness and jaundice. And traditional Chinese medicine external washing can enhance the intestinal peristalsis of neonates and promote defecation, which is very beneficial for the disappearance of jaundice symptoms. Furthermore, the fetus lives in amniotic fluid in the womb, and a similar environment can be imitated when taking a traditional Chinese medicine bath, so it is more suitable for neonates.

[0004] Fetal jaundice is characterized by the appearance of jaundice on the skin of the baby after birth. Because the cause is related to the fetus, it is called "fetal jaundice" or "fetal jaundice". There are two main causes of neonatal pathological jaundice: internal and external. The internal cause is that the fetus is endowed with damp heat or yang deficiency, cold and dampness in the mother's body; the external cause is mainly that the baby is affected by damp heat or cold and dampness during birth or after birth, with damp heat being more common. The affected organs are the liver, gallbladder, spleen and stomach. The key to the pathogenesis is dampness in the liver and gallbladder, liver failure to dredge and discharge, and bile overflowing. Damp heat accumulation is the most common syndrome of fetal jaundice. Because the pregnant mother's damp heat is toxic, it is passed on to the fetus. This is what "The Treatise on the Causes and Symptoms of Various Diseases·Fetal Jaundice" said: "When the child is in the fetus, the mother's organs are hot, fumigating the fetus, causing the child to be born with yellow body." Or it may be caused by the damp heat evil toxins during birth or after birth. Children's internal organs are not complete, their physical form and qi are not full, and their spleen is not healthy. They are affected by dampness and heat, which cannot be transformed. They are stagnant inside, and their qi is not smooth. The liver and gallbladder are stagnant, which leads to jaundice. After birth, it appears on the skin and face, causing yellow skin. Because dampness turns into heat, and heat is heavier than dampness, the yellow color is bright, often accompanied by heat, which is a sign of Yang jaundice. If the heat toxicity is blazing, jaundice can deepen rapidly. If dampness and heat turn into fire, and the evil is trapped in the yin meridian, there will be dangerous signs of coma and convulsions. If the positive qi is not supported, the qi and yang will be weak. It can cause collapse. Summary of the invention

[0005] The purpose of the present invention is to provide a Chinese medicine composition for treating neonatal jaundice, and at the same time provide a preparation method of the composition into a lotion. The Chinese medicine composition can effectively improve and treat neonatal jaundice, while reducing the side effects of the drug, and can be made into a lotion for easy use by infants.

[0006] In order to achieve the above object, the technical solution adopted by the present invention is:

[0007] The first aspect of the present invention provides a Chinese medicine composition for treating neonatal jaundice, comprising the following raw materials in parts by weight:

[0008] 30-50 parts of Scutellaria baicalensis, 10-20 parts of Phellodendron amurense, 4-8 parts of Rhubarb, 8-12 parts of Rhizoma Cyperi, 10-20 parts of Gardenia jasminoides, 10-20 parts of Imperatae cyperi, 10-20 parts of Chrysanthemum, 8-12 parts of Herba Artemisiae Scopariae, 30-50 parts of Artemisia capillaris, 10-20 parts of Atractylodes lancea, and 10-20 parts of Herba Lysimachiae.

[0009] Preferably, the traditional Chinese medicine composition for treating neonatal jaundice comprises the following raw materials in parts by weight: 35-45 parts of Scutellaria baicalensis, 12-18 parts of Phellodendron chinense, 4-6 parts of Rhubarb, 9-11 parts of Radix Codonopsis pilosulae, 12-18 parts of Gardenia jasminoides, 12-18 parts of Imperata rhizome, 12-18 parts of Chrysanthemum, 9-11 parts of Codonopsis pilosulae, 35-45 parts of Artemisia capillaris, 10-20 parts of Atractylodes lancea, and 10-20 parts of Lysimachia grandiflora.

[0010] The second aspect of the present invention provides a lotion for treating neonatal jaundice, which is prepared from the traditional Chinese medicine composition for treating neonatal jaundice.

[0011] The third aspect of the present invention provides a method for preparing the lotion for treating neonatal jaundice, comprising the following steps:

[0012] Weigh the pieces according to the prescription ratio, add 8-12 times the amount of water each time to extract for 1-2 hours, extract 1-3 times in total, mix the decoctions, concentrate, and centrifuge to remove impurities to obtain the lotion for treating neonatal jaundice.

[0013] Preferably, the concentration is concentration under normal pressure or under reduced pressure.

[0014] Preferably, the rotation speed of the centrifugal impurity removal is 3000-6000r / min.

[0015] The medicinal effects of each medicine in the Chinese medicine composition for treating neonatal jaundice of the present invention are as follows:

[0016] Scutellaria baicalensis has the effects of clearing heat and drying dampness, purging fire and detoxifying, stopping bleeding and stabilizing the fetus; Phellodendron chinense has the effects of clearing heat and drying dampness, purging fire and removing steaming, and detoxifying and treating sores; Rhubarb has the effects of purging and attacking accumulation, clearing heat and purging fire, cooling blood and detoxifying, removing blood stasis and promoting menstruation, and promoting dampness and relieving jaundice; Rhizoma Cibotii has the effects of clearing heat and promoting dampness, dispersing blood stasis and detoxifying; Gardenia jasminoides has the effects of purging fire and relieving restlessness, clearing heat and promoting dampness, cooling blood and detoxifying; external use reduces swelling and relieves pain; Imperatae rhizome has the effects of cooling blood and stopping bleeding, clearing heat and promoting diuresis; Chrysanthemum has the effects of dispersing wind and clearing heat, calming the liver and improving eyesight, clearing heat and detoxifying; Herba Cyperi has the effects of clearing heat and promoting dampness, cooling blood and dispersing blood stasis; Artemisia capillaris has the effects of clearing dampness and heat, promoting the bile and relieving jaundice; Atractylodes has the effects of drying dampness and strengthening the spleen, dispelling wind and dispersing cold, and improving eyesight; Herba Lysimachiae has the effects of promoting dampness and relieving jaundice, and promoting diuresis and relieving stranguria.

[0017] The compatibility principle of the Chinese medicine composition for treating neonatal jaundice of the present invention is as follows:

[0018] The jaundice lotion of the present invention is summarized on the basis of many years of clinical practice, and is mainly designed for the most common syndrome type of neonatal jaundice, "damp-heat accumulation type". The whole prescription has the effects of clearing heat and dampness, promoting bile and relieving jaundice. In the prescription, Artemisia capillaris, Gardenia jasminoides and Scutellaria baicalensis are the main drugs. Artemisia capillaris is bitter and pungent, slightly cold in nature, and has the effects of clearing heat and dampness, promoting bile and relieving jaundice. The "Shennong's Herbal Classic" says that it "mainly treats rheumatism, cold and heat evil qi, and heat-stagnation jaundice", is good at clearing dampness and heat in the liver, gallbladder, spleen and stomach, and makes it come out through urination, which is an important medicine for treating jaundice; Gardenia jasminoides, bitter in taste and cold in nature, can reach the upper, middle and lower three burners, and has the effect of clearing dampness and heat in the three burners, liver and gallbladder; Scutellaria baicalensis is bitter in taste and cold in nature, and has the effect of clearing heat and drying dampness. The "Classic" says that it is the main heat jaundice, good at clearing dampness and heat in the lungs, stomach, gallbladder and large intestine, and is especially good at clearing dampness and heat in the middle and upper burners and removing evil heat from the skin. The above three have a complementary effect when used together, can enhance the effect of promoting dampness and relieving jaundice, and are the main drugs together. Huangbai, bitter and cold in nature, is good at clearing heat and drying dampness, especially removing dampness and heat from the bladder and large intestine to treat jaundice; Guangqiancao is good at clearing dampness and heat from the lower jiao, promoting bile secretion, and guiding dampness and heat out through urination; Imperata root is sweet, cold and clearing, good at penetrating visceral heat and promoting urination, guiding dampness downward; Atractylodes can reach the skin surface, open the skin and remove dampness, and has a fragrant taste, which can wake up the spleen and transform the dampness of the middle jiao spleen and stomach. Because it is pungent and warm in nature, it is added to the bitter and cold medicines to make its medicinal properties play a role of opposites and complements each other, making the whole prescription cold but not stagnant. These four herbs can be used together to remove dampness and heat from the three jiaos, inside and outside, and help the monarch medicine to strengthen the effect of removing dampness, promoting bile secretion and relieving jaundice, and they are all ministers. Chrysanthemum is light and evacuating, and can penetrate heat and go out to help remove dampness; Tianjihuang and Xihuangcao are Lingnan specialty medicinal materials, both of which have the effect of clearing heat and removing dampness, and are good at promoting liver and gallbladder dampness and relieving jaundice; these three herbs can assist the monarch and ministers and strengthen the effect of removing dampness and relieving jaundice. Rhubarb is bitter and cold. The Ben Jing says that it "cleans the intestines and stomach, and removes the old and brings in the new." Its qi is heavy and turbid, and it moves but does not stay. It can clear the bowels, reduce turbidity, remove blood stasis and relieve jaundice. A small amount of it in the prescription can lead the power of other medicines to the gate of the soul, so that the turbid accumulation of dampness and heat can be discharged from below. This prescription can clear the dampness and heat evil inside and outside, and clear the liver, gallbladder, stomach, intestines and bladder, so that the evil has a way out, so as to achieve the effect of clearing heat and dampness, promoting bile and relieving jaundice.

[0019] Compared with the prior art, the present invention has the following beneficial effects:

[0020] The Chinese medicinal composition for treating neonatal jaundice of the present invention has the advantages of significant efficacy, rapid effect and no toxic side effects when used for treating neonatal jaundice. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 Liquid chromatogram of baicalin for reference substance (A), test substance (B) and negative control (C). DETAILED DESCRIPTION

[0022] The specific embodiments of the present invention are further described below. It should be noted that the description of these embodiments is used to help understand the present invention, but does not constitute a limitation of the present invention. In addition, the technical features involved in each embodiment of the present invention described below can be combined with each other as long as they do not conflict with each other.

[0023] Example 1

[0024] This embodiment provides a traditional Chinese medicine composition for treating neonatal jaundice, comprising the following raw materials in parts by weight: 40 parts of Scutellaria baicalensis, 15 parts of Phellodendron chinense, 5 parts of Rhubarb, 10 parts of Radix Achyranthis Bidentatae, 15 parts of Gardenia jasminoides, 15 parts of Imperatae cylindricae, 15 parts of Chrysanthemum, 10 parts of Coptis chinensis, 40 parts of Artemisia capillaris, 15 parts of Atractylodes lancea, and 15 parts of Desmodium grandiflorum.

[0025] This embodiment provides a lotion for treating neonatal jaundice, which is prepared using the above-mentioned Chinese medicine composition, and the preparation method comprises the following steps:

[0026] Weigh the slices according to the prescription ratio, add 10 times the amount of water each time and extract for 1 hour, extract 3 times in total, mix the three decoctions, and choose to concentrate at normal pressure or under reduced pressure according to the production equipment conditions, centrifuge at 5000r / min to remove impurities and purify, and fill in oral liquid medicinal high-density polyethylene bottles, 500mL per bottle. Shake well when using, twice a day, 250mL each time, dilute with appropriate amount of warm water and wash externally.

[0027] Baicalin is the active ingredient of Scutellaria baicalensis, the main herb in the prescription, and the solid quality can directly reflect the dissolution of other ingredients. Therefore, baicalin and solid quality were selected as the comprehensive evaluation indicators of the reflux extraction process of jaundice lotion.

[0028] 1. Establish a method for determining the content of baicalin in jaundice lotion:

[0029] 1.1. Chromatographic conditions: Waters e2695 high performance liquid chromatograph. Chromatographic column: phenomenex EVOC 18 (particle size: 5 μm, length: 4.6 mm × 250 mm); mobile phase: acetonitrile-0.1% formic acid gradient elution: 0-15 min, 5-15% acetonitrile; 15-25 min, 15-20% acetonitrile; 25-28 min, 20-25% acetonitrile; 28-40 min, 25% acetonitrile; 40-45 min, 25-30% acetonitrile; 45-50 min, 30-35% acetonitrile. Flow rate: 1 mL / min, column temperature: 25°C, detection wavelength: 280 nm.

[0030] 1.2. Preparation of reference solution: Take methanol to prepare reference solution containing 83.28096 μg and 832.8096 μg of baicalin per 1 mL, and set aside.

[0031] 1.3. Preparation of test solution: Take 5 mL of the prepared jaundice lotion and place it in a 25 mL volumetric flask. Add methanol to dilute to the scale, shake well, and take the filtrate.

[0032] 1.4. Preparation of negative solution: Weigh the negative solution of Scutellaria baicalensis according to the above-mentioned jaundice lotion formula, extract twice, add 6 times the amount of water each time, extract for 1 hour, filter, combine the filtrate, and concentrate the drug solution to 500mL. Prepare the negative control solution according to the preparation method of the test solution in step 1.3.

[0033] 1.5. Specificity investigation: The above-mentioned reference solution, test sample and negative control solution were respectively taken for determination. The results showed that the negative control solution lacking Scutellaria baicalensis had no absorption at the corresponding position of the chromatographic peak of baicalin, indicating that the method has good specificity. Figure 1 .

[0034] 1.6. Linear relationship investigation: 0.1, 0.2, 0.4, 0.6, 0.8, and 1.0 mL of the reference solution in step 1.2 were respectively measured and placed in a 1 mL volumetric flask. Methanol was added to dilute to the scale and shaken to obtain a series of reference solutions. 5 μL was injected for determination under the above chromatographic conditions. A standard curve was plotted with the injection volume as the abscissa (X) and the peak area as the ordinate (Y). The standard curve of baicalin was Y=16957X+19585 (r=0.9999), and the linear range was 427.0968-470.968 ng.

[0035] 1.7 Stability test: Take the test solution and inject it at 0, 1, 2, 4, 8, 12, and 24 hours, record the peak area and calculate the RSD. The results show that the RSD of the baicalin peak area is 0.96%, and the sample solution is stable within 24 hours.

[0036] 1.8 Repeatability test: According to the above method for preparing the test solution, 6 test solutions were prepared, and the samples were injected and measured respectively. The peak area was recorded and the baicalin content and RSD were calculated. The results showed that the RSD of baicalin was 1.44%, and the method had good repeatability.

[0037] 1.9. Sample recovery test: Measure 2 mL of a sample with a known content, add 50%, 100% and 150% of the baicalin reference substance in three parallel portions, prepare according to the preparation method of the test solution, inject and measure, record the peak area and calculate the baicalin content and recovery rate. The results showed that the average recovery rate of baicalin was 95.48% and the RSD was 1.00%. This shows that the method is stable and feasible. See Table 1 for details.

[0038] Table 1 Baicalin recovery test results (n = 9)

[0039]

[0040] 2. Determination of solid matter quality:

[0041] Accurately measure 25 mL of each sample and place it in an evaporating dish of known mass (W 1 ), first placed in a water bath to evaporate to dryness, then dried at 105 ° C for 3 h, and the total mass (W 2 ), calculate the solid mass according to the following formula (V is the constant volume).

[0042]

[0043] 3. Orthogonal experiment: This experiment selected three levels of material-liquid ratio, extraction time and extraction times for orthogonal experiment. The factor level design is shown in Table 2. According to the prescription ratio, 9 portions of decoction pieces were weighed, each 310g, according to L9(3 4 ) was extracted under the conditions of the orthogonal table, filtered, the filtrate was concentrated and fixed to 500 mL, and the mass of baicalin and solid matter was determined. The results are shown in Tables 3 and 4.

[0044] Table 2 Factor level table

[0045]

[0046] Table 3 Orthogonal test results

[0047]

[0048]

[0049] Table 4 Variance analysis table

[0050] Sources of variation Sum of Squares of Deviations Degrees of Freedom variance F P A 95.86 2.00 47.93 7.15 P>0.05 B 53.50 2.00 26.75 3.99 P>0.05 C 1956.45 2.00 978.22 145.84 P<0.01 D(blank) 13.42 2.00 6.71 1.00

[0051] F 0.01 (1, 2) = 99.00F 0.05 (1, 2) = 19.00

[0052] The test results show that the factors affecting the extraction effect are as follows: extraction times (C) > water addition (A) > extraction time (B), and the best process combination is A. 2 B 2 C 3 The variance analysis showed that compared with the blank group, factor C (number of extractions) had a significant effect on the test results, while factor A (amount of water added) and factor B (extraction time) had no significant effect on the test results. Considering the comprehensive considerations of shortening the production cycle and saving energy and reducing consumption, the extraction process was selected as follows: A 2 B 1 C 3 , that is, extract 3 times, add 10 times the amount of water each time, and extract for 1 hour.

[0053] 4. Optimal extraction process verification test: According to the prescription ratio, 3 portions of Radix Scutellariae and other decoction pieces were weighed, each portion was 310 g, extracted and filtered according to the preferred process conditions, the filtrate was concentrated and fixed to 500 mL, the solid mass and baicalin content were determined according to the above method, and the comprehensive score was calculated. The results are shown in Table 5.

[0054] Table 5 Optimal extraction process verification results

[0055] Test No. Solid mass / g <![CDATA[Baicalin content μg·mL -1 > Comprehensive rating 1 105.50 7975.38 95.56 2 106.84 7914.28 95.81 3 109.15 7683.98 95.50 average value 7857.88 107.17 95.62

[0056] The results showed that the average baicalin content of three parallel verifications was 7857.88 μg / mL, the average solid mass was 107.17 g, and the average comprehensive score was 95.62, which was not much different from the maximum comprehensive score of the orthogonal experiment, indicating that the screened extraction process conditions were basically stable.

[0057] 5. Concentration process investigation: This experiment compares the atmospheric concentration and vacuum concentration processes, and uses the baicalin retention rate as an evaluation index to optimize the concentration process. Weigh two portions of extracts extracted according to the verified process conditions, each 4000g, and concentrate them by atmospheric concentration and vacuum concentration (vacuum degree -0.085MPa), respectively. Each concentrate is concentrated to about 190g, weighed, and the baicalin content is determined, and the retention rate is calculated. The results are shown in Table 6.

[0058] Baicalin retention rate = baicalin content in the concentrate / baicalin content in the extract × 100%

[0059] Table 6 Concentration process investigation results

[0060]

[0061]

[0062] The results showed that the baicalin retention rate of the normal pressure concentration process was slightly higher than that of the reduced pressure concentration process, and there was no significant difference between the two. Normal pressure concentration or reduced pressure concentration can be selected according to the conditions of the production equipment.

[0063] 6. Purification process investigation

[0064] 6.1. Selection of purification method: Take two portions of the concentrate equivalent to 310 g of the decoction piece, remove impurities by centrifugation (5000r / min) and filtration (200 mesh), collect the supernatant, add purified water to each portion to adjust to 600 mL, put into 200 mL oral liquid medicinal high-density polyethylene bottles (n=3), leave for 7 days, observe the precipitation of the liquid and determine the mass of baicalin and solid matter. The results are shown in Table 7.

[0065] Table 7 Effects of different impurity removal methods on preparations (n=3)

[0066] Test No. Impurity removal method Precipitation of the drug solution after 7 days Baicalin content (μg / mL) Solid mass (g) 1 Filtration There is a lot of sediment, which can be shaken off 6168.9 31.06 2 Filtration There is a lot of sediment, which can be shaken off 6286.26 31.48 3 Filtration There is a lot of sediment, which can be shaken off 6399.24 30.99 4 Centrifugation Less precipitation, can be shaken off 6405.58 29.91 5 Centrifugation Less precipitation, can be shaken off 6309.17 30.28 6 Centrifugation Less precipitation, can be shaken off 6380.29 30.28

[0067] The results showed that the precipitates produced by both centrifugal removal and filtration removal could be shaken off, but the precipitate produced by centrifugal removal was less than that produced by filtration removal, and the content of baicalin in the medicinal solution after centrifugal removal was higher than that after filtration removal. Therefore, combined with the production equipment conditions, centrifugal removal was determined to be the impurity removal method for this product.

[0068] 6.2. Determination of the process parameters for centrifugal removal: Three portions of slices were weighed according to the prescription ratio, 310 g each, extracted and concentrated according to the process conditions determined above, and the concentrates were centrifuged at speeds of 3000 r / min, 4000 r / min, and 5000 r / min, respectively. The supernatant was collected and cooled, and purified water was added to 600 mL for each portion, which was placed in a 200 mL oral liquid medicinal high-density polyethylene bottle (n=3) and left for 7 days. The precipitation of the medicinal solution was observed, and the baicalin content and solid mass in the medicinal solution were determined. The results are shown in Table 8.

[0069] Table 8 Effect of different centrifugation conditions on preparations

[0070]

[0071]

[0072] The results showed that after the samples were removed at three speeds, the precipitate produced by the liquid medicine could be shaken off after being placed for 7 days, and the removal effect of the speed of 5000r / min was better than that of 3000r / min and 4000r / min. Therefore, the speed of centrifugal removal of this product was determined to be 5000r / min.

[0073] 7. Packaging: Fill into oral liquid medicinal high-density polyethylene bottles, 500 mL per bottle.

[0074] 8. Determination of packaging specifications and usage and dosage:

[0075] Specifications: 500mL per bottle.

[0076] Dosage and Administration: Shake well before use, twice a day, 250 mL each time, dilute with appropriate amount of warm water and wash externally.

[0077] Treatment results: The jaundice wash of the present invention treated 80 patients with neonatal jaundice, including 29 hospitalized children, whose bilirubin indexes were all >205 μmol / L before admission. After 2-5 days of treatment, 27 cases were cured, accounting for 93.10%, 2 cases were improved, and the effective rate was 100%; 51 outpatient children, whose bilirubin indexes were all >205 μmol / L before treatment, after 3-14 days of treatment, 46 cases were cured, accounting for 90.20%, 5 cases were improved, the effective rate was 100%, and no side effects were observed; the results show that the present invention has the advantages of significant efficacy, quick effect, and no toxic side effects.

[0078] Efficacy evaluation criteria: Cured: jaundice subsides, other symptoms disappear, and laboratory indicators are normal. Improved: jaundice and other symptoms are alleviated, bilirubin is normal or decreased, and other laboratory indicators are improved.

[0079] The embodiments of the present invention are described in detail above, but the present invention is not limited to the described embodiments. For those skilled in the art, various changes, modifications, substitutions and variations of these embodiments are made without departing from the principles and spirit of the present invention, and still fall within the protection scope of the present invention.

Claims

1. A Chinese medicine composition for treating neonatal jaundice, characterized in that: The preparation method comprises the following raw materials in parts by weight: 30-50 parts of Scutellaria baicalensis, 10-20 parts of Phellodendron amurense, 4-8 parts of Rhubarb, 8-12 parts of Rhizoma Cyperi, 10-20 parts of Gardenia jasminoides, 10-20 parts of Imperatae cyperi, 10-20 parts of Chrysanthemum, 8-12 parts of Herba Artemisiae Scopariae, 30-50 parts of Artemisia capillaris, 10-20 parts of Atractylodes lancea, and 10-20 parts of Herba Lysimachiae.

2. The Chinese medicine composition for treating neonatal jaundice according to claim 1, characterized in that: The preparation method comprises the following raw materials in parts by weight: 35-45 parts of Scutellaria baicalensis, 12-18 parts of Phellodendron amurense, 4-6 parts of Rhubarb, 9-11 parts of Radix Codonopsis pilosulae, 12-18 parts of Gardenia jasminoides, 12-18 parts of Imperatae cylindricae, 12-18 parts of Chrysanthemum, 9-11 parts of Herba Codonopsis pilosulae, 35-45 parts of Artemisia capillaris, 10-20 parts of Atractylodes lancea, and 10-20 parts of Herba Lysimachiae.

3. A lotion for treating neonatal jaundice, characterized in that: The composition is prepared from the Chinese medicine composition for treating neonatal jaundice according to claim 1 or 2.

4. A method for preparing the lotion for treating neonatal jaundice according to claim 3, characterized in that: The following steps are involved: Weigh the pieces according to the prescription ratio, add 8-12 times the amount of water each time to extract for 1-2 hours, extract 1-3 times in total, mix the decoctions, concentrate, and centrifuge to remove impurities to obtain the lotion for treating neonatal jaundice.